Hastanede Kemoterapi Alan Hastaların Yaşam Kalitesi ve Bunu Etkileyen Faktörler

Amaç: Bu araştırma kemoterapi alan hastaların yaşam kalitesi ve bunu etkileyen faktörlerin belirlenmesi amacıyla yapıldı. Hastalar ve Yöntem: Tanımlayıcı nitelikteki bu araştırma, bir kamu hastanesi onkoloji polikliniğinde kemoterapi alan 116 hasta ile yürütüldü. Bulgular: Araştırmaya katılan hastaların yarıdan fazlası %62.9 kadındı. Hastaların fiziksel iyilik hali, sosyal yaşam ve aile durumunun kadın ve erkeklerde farklılık göstermediği ancak, fonksiyonel iyilik hali ölçek puanlarının p

The Life Quality of The Patients Receiving Chemotherapy In The Hospital and The Influencing Factors

Purpose: The objective of this research is to determine the quality of life the patients having chemotherapy and the influencing factors. Patients and Methods: This descriptive research has been carried out with 116 patients receiving chemotherapy in the oncology outpatient clinic of a public hospital. Results: More half of the patients 62.9 % taking part in the research were women. It has been observed that there is no difference between the men and women in terms of their health condition, social life and personal status, and it has also been determined that the scale scores of functional state of health of men are higher than women while subscale scores of emotional conditions of women are higher than men. It has been observed that there is a positive correlation between the income and social life of patients and their functional state of health. The functional state of the health of the patients living with their family and having no financial problems were higher compared to those having financial problems. Conclusion: The quality of life the patients having chemotherapy is affected by factors such as gender of the patients, their educational background, their family types, their working / financial conditions, whether they have inpatient or ambulatory treatment. However, the age of the patient, their martial status or whether they live in an urban or rural area have no influence on their quality of the life.

Keywords:

chemotheraphy, quality of life cancer, nursing,

PDF

___

Gültekin M, Boztaş G. (Ed.)Türkiye Kanser İstatistikleri. Sağlık Bakanlığı, Türkiye Halk Sağlığı Kurumu. 2014:43.

Aslan Ö, Vural H, Kömürcü Ş, Özet A. Kemoterapi alan kanser hastalarına verilen eğitimin kemoterapi semptomlarına etkisi. Cumhuriyet Üniversitesi Hemşirelik Yüksekokulu Dergisi 2006;10:18-24.

Chemotherapy and Quality of Life. Psycho-oncology Co-operative Research Group (PoCoG) Quality of Life Office (2008). (online resource http://www.pocog.org.au/content.aspx?page=Chemotherapy). Erişim Tarihi:22.11.2014

Wenzel L, Vergote I, Cella D. Quality of life in patients receiving treatment for gynecologic malignancies: Special considerations for patient care. Int J Gynecol Obstet 2003;83:211-229

Pınar G, Algıer L, Colak M, Ayhan A. Jinekolojik kanserli hastalarda yaşam kalitesi. Uluslararası Hematoloji- Onkoloji Dergisi, 2008;3:141-148.

Bayram Z, Durna Z, Akın S. Quality of life during chemotherapy and satisfaction with nursing care in Turkish breast cancer patients. European Journal of Cancer Care. 2014;23:675-684

Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy Scale: Development and validation of the general measure. J Clin Oncol 1993;11:570-579.

Çetiner M., Kalaca S., Birtaş E., et al Hematopoietik Kok Hucre Nakli Yapılan Hastalarda Yaşam Kalitesinin Değerlendirilmesi. Turkish Journal of Hematology, 2004;21(Supplement) 6-7.

Kızılcı S. Kemoterapi alan kanserli hastalar ve yakınlarının yaşam kalitesini etkileyen faktörler. Cumhuriyet Üniversitesi Hemşirelik Yüksekokulu Dergisi 1999;3:18-26.

Shutz AA, Winstead P. Predictors of quality of life in rural patients with cancer. Cancer Nursing. 2001;33:96-101.

Buchanan DR, O’Mara AM, Kelaghan JW, Minasian LM. Quality-of- life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program. J Clin Oncol 2005;23:591-598.

Greimel E, Thiel I, Peintinger F, Cegnar I, Pongratz E. (Prospective assessment of quality of life of female cancer patients. Gynecol Oncol, 2002;85:140-147.

Lampic C, Peterson VW, Larsson G, Sjoden O, Essen L. Anxiety and depression in hospitalized patient with cancer: Agrement in patient- staff dyads. Cancer Nursing, 2003;19:419-427.

Reis N. Jinekolojik Kanser ve Tedavilerinin Kadın Cinsel Sağlığına Etkileri. C.Ü. Hemşirelik Yüksekokulu Dergisi. 2003;7:35-40.

Crivellari D, Bonetti M, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, Thürlimann B, et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer:The International Breast Cancer Study Group Trial VII. J Clin Oncol 2000;18:1412-22.

Usta Yeşilbakan Ö, Durmaz Akyol A, Çetinkaya Y, Altın T, Ünlü D. Kemoterapi tedavisi alan hastaların tedaviye bağlı yaşadıkları semptomlar ve yaşam kalitesine olan etkisinin incelenmesi. Ege Üniversitesi Hemşirelik Yüksekokulu Dergisi. 2005;21:13-31.